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2Summary
Several arguments suggest that Minimal Change Nephrotic Syndrome
(MCNS) results from yet unknown systemic disorder of T cell function.
By screening a cDNA library from T cell relapse, we identified a new
Pleckstrin homology (PH) domain-containing protein encoded by a gene
located on chromosome 16q24. Its expression was restricted to fetal
liver, kidney and PBMC in which two transcripts were identified. The
first species (c-mip) was expressed in normal PBMC but weakly detected
in PBMC from MCNS patients. The second form, lacking a part of the N-
terminal PH domain (Tc-mip, standing for Truncated c-maf inducing
protein), was specifically recruited in CD4+ T cells of patients with
MCNS. Overexpression of Tc-mip in T cells induced c-maf,
transactivateted the IL-4 gene and downregulated IFNg expression,
characteristic of a Th2 commitment. Moreover, the overexpression of
Tc-mip induced T cell clustering and a cellular redistribution of the
cytoskeleton-associated L-plastin, by a PI3 kinase independent pathway.
T-cmip represents therefore the first identified protein, which links
proximal signaling to c-maf induction.
3Introduction
Minimal Change Nephrotic Syndrome (MCNS) is the most frequent
glomerular disease in children, characterized by heavy proteinuria with
relapse and remission courses (1). Although no immune cell infiltration,
or immune complex deposit could be identified in the kidney, many
arguments suggest that MCNS results from a systemic disorder of T cell
function (2). Indeed, relapses often occur in the context of immune
challenge initiated by infectious, allergic stimuli or vaccine and they
are usually sensitive to drugs known to inhibit the immune system
(i.e/glucocorticoids, ciclosporine and ciclophosphamide). Nonetheless,
the link between immune disorders and this glomerular disease remains
unresolved.
Recently, we have shown that T lymphocytes from MCNS were rather
driven toward a Th2 phenotype. Supporting this view, we found that T
cells display a downregulation of the IL-12 receptor b 2 subunit (IL-12R
b 2), whereas the second component of the IL-12R, the b 1 chain, was
normally expressed (3). The IL-12R b 2 is selectively expressed by Th1
cells and plays a key role in the transduction of IL-12 signaling through
the Jak/Stat pathway. The downregulation of the IL-12R b 2 is
compatible with a lack of IL-12 production during relapse (4). The
commitment of MCNS T cells along the Th2 pathway involves the
4recruitment of c-maf of which the functional expression appears closely
related to MCNS activity (Valanciute A., submitted). It has been shown
that c-maf promotes T helper cell type 2 (Th2) and attenuates Th1
differentiation (5), (6). As a matter of fact, patients with MCNS are
often unable to mount an effective Th1 response that might account for
observed defects in delayed-type hypersensitivity response and recall
response to antigens (2, 7).
In order to understand in depth the molecular mechanisms involved in
this T cell dysfunction, we recently identified by subtractive cloning
and differential screening, transcripts upregulated during the active
phase of the disease (3). Among them, we isolated a truncated form of a
new protein, involved in c-maf signaling pathway, that we named Tc-
mip (for truncated c-maf inducing protein). The natural transcript, c-
mip, corresponds to the product of the Kiaa1694 gene, previously
identified in the human brain (8). Tc-mip exhibited a deletion within
the N-terminal pleckstrin homology domain (PH) of c-mip and its
transcript is selectively induced in active phase of the disease whereas
it is hardly detected in T cells of normal subjects. We show here that
overexpression of Tc-mip in Jurkat T cells, strongly induces the c-maf
protein and increases the IL-4 promoter-mediated transcription,
whereas it concomitantly represses the INF g  expression. Moreover,
overexpression of Tc-mip in Jurkat T cells, induces T cell clustering and
5cellular redistribution of L-plastin, a cytoskeleton-associated protein, by
a PI3 kinase independent pathway.
These results suggest that Tc-mip plays a critical role in Th2 signaling
pathway and represents the first proximal signaling protein which links
TCR-mediated signal to the activation of c-maf Th2 specific factor.
6Material and Methods
Patients. The cohort of patients analyzed in this study has been
described previously (9). In children, the criteria of the International
Study of Kidney Diseases were used for diagnosis and management of
MCNS (10). In adults, the diagnosis of MCNS or Membranous
Nephropathy (MN) was confirmed by renal biopsy before inclusion. All
patients with relapse (children and adults) had proteinuria over
3g/24h, and low serum albumin levels (below 3 g/dl), at the time of
blood sampling, which was performed before the beginning of steroid
treatment.
Remission samples were collected during periods of inactive disease,
defined by a proteinuria below 0.2g/24h. Controls consisted of normal
children studied while undergoing routine analysis, normal adult
volunteers, as well as patients with MN.
Informed consent was obtained from the parents and whenever possible
from the pediatric patients, as well as from adult patients and normal
volunteers.
Antibodies and reagents. Immunoselection of T cell subsets and
monocytes was performed using a cocktail of hapten-conjugated
antibodies (Miltenyi Biotech. GmbH, Auburn, CA, USA).
7A polyclonal antibody common to c-mip and Tc-mip was produced
against a peptide of 15 aa, corresponding to amino acids 194-209 of the
Tc-mip (Eurogentec, Belgium). Antibodies against c-maf (sc-7866) and
phospho Akt (ser-473) were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA) and New England Biolabs (Beverly, Ma, USA),
respectively. Monoclonal antibody of L-Plastin (Anti-LPLA4.1) was a gift
of Drs Eric J. Brown and Hua Shen (University of California, San
Francisco, CA) and was used at 1 m g/ml. Wortmanin was purchased from
Sigma (Paris, France).
Purification of PBMC and T cell subsets. Peripheral blood
mononuclear cells (PBMC) and T cell subsets were purified as previously
described (9). The purity of the preparations was 88-96%, as assessed
by flow cytometric analysis, using FITC-conjugated CD2, CD4+, CD19,
and CD8 antibodies. Activation was performed with 5 m g/ml PMA
(phorbol ester myristate) and 5 m g/ml calcium ionophore (ionomycin),
for four hours. Th1 and Th2 polarized T cells were a gift of Dr Pellegrini
(Institut Pasteur, Paris). They were isolated from blood umbilical cord
and cultured under Th1 (in the presence of IL-12 and anti-IL-4
antibody) or Th2 (in the presence of IL-4 and anti-IL-12 antibody)
skewing conditions.
Immunocytochemistry. Cells were cytospun at 105 cells/slide, fixed
and permeabilized by using methanol at –20°C, then processed for
8immunoreactivity. Cells were incubated in the blocking solution (10%
normal sheep serum (NSS), 1% Bovine Serum Albumin (BSA) for 40 min,
washed twice with phosphate-buffered saline (PBS), then incubated with
Tc-mip (1/200) or L-plastin (1 m g/ml) antibody (in 5% NSS, 1% BSA,
0.1% Tween 20) for 2 hours at room temperature. Slides were washed
three times with PBS, then incubated with anti-rabbit Cy3-labelled
antibody (1/1000 in blocking solution) for 30 min. Slides were
mounted in a Vectashield DAPI (Vector laboratories, Burlingame,
California), and analyzed on an Axioplan Zeiss microscope equipped for
epifluorescence. The percentage of positive cells was determined on an
average of 200 cells.
Reverse transcription-PCR (RT-PCR). Total RNAs were treated by
DNase I and purified using Rneasy kit (Qiagen SA), following the
supplier’s protocol. The 5’ and 3’ primers of Tc-mip and c-mip were
selected in the first respective exon. The sequence of the primers, and
PCR parameters are indicated in Table 1.
Semiquantitative RT-PCR was performed as previously reported (9).
Each cycle consists of denaturation at 94°C for 30 sec, annealing at the
indicated temperature for 30 sec and extension at 68°C for 2 min.
Amplified products were detected on Southern blots with [ 32P]  labeled
specific internal oligonucleotide probes and quantified by using a
phosphoimager (Storm 840, Molecular dynamics SA), coupled to the
9ImageQuant v1.11 analysis software. PCR reactions were normalized for
GAPDH expression.
Northern blot. Human multiple-tissue Northern blots (Clontech, CA)
were hybridized with a a 560 bp cDNA probe common to c-mip and Tc-
mip. Hybridization and blot processing were performed as previously
described (3).
DNA sequencing. Preparation and sequencing of double stranded
plasmid DNA template and sequencing were performed as previously
reported (3). Nucleic acid and protein database searches were done
using resources of the National Center Biotechnology Information.
Western blots and electromobility shift assays (EMSA)
Preparation and quantification of protein extracts, as well as SDS-PAGE
immunoblotting, and EMSA experiments, were performed as previously
described (9). The double-stranded oligonucleotide probes (100 ng),
(Genset, France) consisting of the wild (5'-
GGAATTGCTGACTCAGCATTACT-3') and the mutant (5'-
GGAATTGCTGACTCATTGTTACT-3') MAREs containing the c-Maf
recognition sequence (underlined).
Cloning of the 5’end of c-mip by rapid amplification of cDNA
ends (RACE). Additional sequence upstream of the 5’end of the c-mip
mRNA was explored by using the 5’/3’RACE kit (Clontech) and an
universal antisense primer included in the kit and a 28 mer antisense
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oligonucleotide located at the position 145-172 of the c-mip-exon 1 (5’-
GCTGAGAAAGGTCCGCGGGTGCCGGATG-3’). The PCR product was blunt
ended and cloned into Topo Zero blunt end vector (Invitrogen),
according to manufacturer’s protocol. Preparation and sequencing of
double stranded plasmid DNA template and sequencing were
performed as previously described (3).
Plasmids construction. The cDNA corresponding to the coding
sequences of Tc-mip and c-mip were obtained by RT-PCR using PBMC
RNA from a patient with MCNS relapse and a normal subject,
respectively. The specific primers are reported in table 1. The amplified
products were subcloned into pcDNA3.1/V5-His TOPO cloning vector
(Invitrogen, CA). The IL-4 promoter chloramphenicol acetyltransferase
(IL4-CAT) plasmid (fragment corresponding to -65 base pairs upstream
of the IL-4 transcription initiation start site) was a gift of Dr V Casolaro
(Johns Hopkins University School of Medicine).
Transient transfections. Jurkat T cells were obtained from the
American Type Culture Collection (ATCC, Manassas, VA). Cells were
grown in RPMI 1640 supplemented with 10% FCS. Transient
transfections were performed by electroporation of 30x106 cells with 30
m g of each plasmid (Tc-mip, c-mip or empty vector), or in combination
with 10 m g of CAT-IL4-reporter construct, using a Bio Rad Gene Pulser
set at 250V and 960 m F. The transfected cells were allowed to recover
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overnight, then were divided into identical aliquots in a 24 well plates.
One aliquot was left unstimulated whereas the other was stimulated
with OKT3 ascite fluid (1:5000) for 6 hours. In some experiments,
wortmanin (100 nM) was added to the culture medium 6 hours
following transfection and left overnight. CAT assays were performed
according to the manufacturer’s protocol (Promega, Madison, USA).
CAT activities, normalized by protein content, were determined using a
liquid scintillation counting assay (Packard, Meriden CT), and were




1-Identification and characterization of Tc-mip
A Tc-mip cDNA clone (4.1kb, GenBank accession number: AY172689)
was isolated by differential screening of a full length cDNA library,
generated from T cell-enriched PBMC of MCNS relapse, using subtracted
probes from relapse versus remission (unpublished data). The Tc-mip
mRNA corresponds to an alternative species of c-mip (4.2 kb), isolated
from human brain8. Both Tc-mip and c-mip are transcribed from a
single gene comprising 21 exons spanning 268 Kb in length and located
on chromosome 16q24 (Fig 1). A Tc-mip 5’ RACE did not reveal
upstream 5’ sequence in c-mip and Tc-mip (data not shown), suggesting
that both mRNA are transcribed from distinct promoter regions.
The Tc-mip and c-mip cDNAs contain an open reading frame of 2040
and 2220 nucleotides, encoding 679 (75kDa) and 739 (85kDa) amino
acid proteins respectively. Both initiation codons (ATG) are flanked by
the Kozak consensus sequence. The c-mip protein contains a pleckstrin
homology (PH) domain encoded by exons 1, 2, 3 and 4. The PH domain
starts at position 38 of exon 1 that encodes 66 amino acids. The Tc-mip
transcript does not contain the first exon of c-mip but starts with a new
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145 nucleotide-exon, encoding 6 amino acids and which is located 50
Kb downstream of c-mip-exon 1 on the genome (Fig 1A). Thus, Tc-mip
exhibit a N-terminal truncation of 29 aa of the PH domain. This
truncation delate the b  sheet 1,  the b  sheet 2 as well as the loop b 1b 2 of
the PH domain including but the rest of the protein remains unchanged
(Fig 1B). Beside the PH domain, Tc-mip and c-mip proteins contain a
leucine-rich repeat (LRR) domain encoded by the exon 19. The
remainder of the protein does not exhibit significant homology with
others known domains but contains severeal patterns, including protein
kinase C (PKC), casein kinase II and tyrosine, phosphorylation sites. The
truncation of Tc-mip removes the putative Thr 61, Ser 62 and Lys 63
PKC phosphorylation sites as compared to c-mip.
We hybridized multiple-tissue Northern blots with a cDNA probe
common to Tc-mip and c-mip (Fig 2A). We only detected a signal at
4.25 kb corresponding to c-mip mRNA. The transcript was highly
expressed in PBMC, kidney and fetal liver and to a lesser extent in adult
brain and liver. We were not able to make a northern blot of Tc-mip
transcript in PBMC of MCNS patients was not done because of the
scarcity of the biological material.
2-Expression of Tc-mip in resting and activated T cells
Since Northern-blot analyses revealed a basal expression of c-mip in
PBMC, we analyzed by semi-quantitative RT-PCR, the relative expression
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of Tc-mip and c-mip mRNA in PBMC subsets purified by
immunomagnetic selection. In resting cells, we found that the c-mip
transcript was expressed in monocytes, CD8+, CD4+ T cells and B
lymphocytes, whereas the Tc-mip transcript was only detected in CD4+
and CD8+ T cells (Fig 2B). In order to determine whether these
transcripts are induced in response to activating conditions, cells were
exposed to phorbol ester myristate (PMA) and calcium ionophore
(ionomycin), for four hours. The expression of c-mip and Tc-mip
mRNAs was markedly downregulated in activated cells (Fig 2B). Then
we analysed the expression their respective proteins by immunoblotting
protein extracts with a polyclonal antibody recognizing the amino acid
sequence 194-209 common to Tc-mip and c-mip proteins. In contrast
with the basal mRNA expression, we were unable to detect Tc-mip by
immunoblotting, whereas c-mip was very faintly or not detected, either
in resting or in activated cells (data not shown), suggesting post
transcriptional regulation mechanisms.
Our recent investigations argue for an early commitment of MCNS T
cells along a Th2 phenotype(3) . The identification of a new gene
upregulated in this disease, markedly expressed in CD+T cells led us to
investigate its expression in polarized CD4+ T cells along Th1 or Th2
pathway. We found that Tc-mip transcript is highly expressed in Th2
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relative to Th1 cells (Fig 2C). This result constitutes an additional
element strengthening the Th2 bias in MCNS.
3-Specific induction of Tc-mip in MCNS.
We analyzed by semi-quantitative RT-PCR the expression level of c-mip
and Tc-mip transcripts during the relapse and the remission phases in
nine patients who experienced a first episode of MCNS. The expression
of Tc-mip mRNA was increased during the relapse in the nine patients
tested, as compared to remission, whereas the eight normal subjects
exhibited very low levels of this transcript (Fig 3A). In contrast, the c-
mip mRNA was expressed to the same low extent in relapse and in
remission phase, and highly expressed in normal subjects in accordance
with the previous experiments (Fig 2B). The upregulation of Tc-mip
mRNA appeared specific to MCNS since four patients with membranous
nephropathy, and a similar range of proteinuria, exhibited a Tc-mip
and c-mip mRNA levels comparable to normal subjects.
We further studied whether the induction of Tc-mip was restricted to a
cell subset during the active phase of the disease. We purified by
immunomagnetic selection, the  CD4+ and non-CD4+ T cells species from
PBMC of patients with relapse. The highest level of Tc-mip mRNA was
observed in the CD4+ T cell subset (Fig 3B).
Since we could not detect Tc-mip protein in normal PBMC cells, we
determined whether it was induced during MCNS disease. We
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immunoblotted total protein extracts from PBMC of six patients in
relapse. We detected a major band of 75kD specific of Tc-mip in
patients with MCNS relapse whereas the signal was undetectable in
normal subjects (fig 3C). In contrast, the expected 85kD band related to
c-mip was weakly detectable in MCNS patients as well as in normal
subjects.
Cellular distribution of Tc-mip was analyzed in PBMC from patients
with MCNS. In relapse, we detected Tc-mip in nuclear and cytoplasmic
compartments, whereas its expression was restricted to the cytoplasm
in remission (Fig 3D). In those samples, 20% of the PBMCs were Tc-mip
positive whereas no cellular staining was visualized in PBMC from
normal controls in accordance with the western blotting results (data
not shown).
4-Tc-mip induces c-maf nuclear expression in Jurkat cells
Recently, we have shown that c-maf was strongly induced in MCNS and
shuttled between nuclear and cytoplasmic compartments during the
relapse and the remission phases, respectively (Valanciute A,
submitted). Since Tc-mip and c-maf are mainly expressed in CD4+T
cells, we examined whether Tc-mip could influence c-maf expression.
We transfected Jurkat cells, which do not express either endogenous c-
mip or Tc-mip, with c-mip or Tc-mip expression vectors. Transfection
with Tc-mip induced c-maf expression at the mRNA and protein level
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(Fig 4A), whereas c-mip promoted a lower but significative induction of
c-maf relative to controls. Importantly, the expression pattern of the c-
maf protein was radically different: in cells overexpressing Tc-mip, c-
maf was primarily detected in nuclei (Fig 4B, upper panel), whereas its
expression was much lower and mostly restricted to periphery of the
cell in c-mip transfected cells (Fig 4B, middle panel). The induction of c-
maf and its nuclear localization in transfected cells did not indicate that
c-maf is transcriptionally active. To address this question, we analyzed
by EMSA experiments, c-maf-dependent DNA binding activity in nuclear
extracts of Tc-mip-transfected Jurkat cells. We only detected a slow
migrating complex binding to MARE probe in Tc-mip transfected Jurkat
cells whereas no complex was visible in c-mip transfected cells This
comlex was specific since it was not formed in the presence of mutant
MARE oligonucleotide (Fig 4C). These results suggest that Tc-mip
induced a functional c-maf in Jurkat T cells.
Confocal fluorescence microscope analysis revealed that the c-mip
protein was restricted to peripheral area of transfected cells, whereas
Tc-mip was diffusely expressed, particularly in nuclear compartment
(Fig 4D). Thus, Tc-mip and c-maf display a similar distribution in nuclei
and cytoplasmic compartments but we xere not able to co-
immunoprecipitate both proteins. Altogether, these results suggest that
truncation of the PH domain affects the cellular distribution of the Tc-
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mip protein, which might regulate the induction and the cellular
compartmentalization of c-maf.
5-Overexpression of Tc-mip results in differential effects on
IL-4 and INF  production
Since c-maf is a transactivator of the IL-4 gene (5,11), the identification
of Tc-mip as an upstream inducer of c-maf lead us to determine
whether Tc-mip could be able to activate the IL4 gene. To that end, we
analyzed the effects of a transient transfection of Tc-mip on IL-4
promoter activity in Jurkat cells. In unstimulated-transfected Jurkat
cells, no significant variation of the IL-4-dependent CAT activity was
detected after transfection with Tc-mip (Fig 5A). When transfected
Jurkat T cells were stimulated with anti-CD3 antibody, Tc-mip and c-
mip induced a four fold and two fold increase of Il-4 promoter activity
relative to control, respectively (Fig 5B).
Since Tc-mip induces the expression of c-maf, we supposed that these
cells acquired a Th2 phenotype. In order to test this hypothesis we
analyzed in parallel IFN g  and IL4 mRNA expression, two reliable
markers of Th1 and Th2 profile   respectively. In unstimulated
transfected cells, Tc-mip, and c-mip did not altered significantly the
the IL-4 and IFN g  mRNA expressions, relative to controls (Fig 5B). Upon
stimulation with anti-CD3 antibody, IL-4 mRNA expression was
considerably increased, whereas IFNg  mRNA expression was sharply
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reduced in Tc-mip-overexpressing cells (Fig 5B). By contrast, c-mip did
not reduced  IFN g  mRNA, whereas the IL-4 mRNA was slightly increased
relative to Tc-mip-transfected cells. This result suggests that signals
emanating from TCR engagement provided additional requirement for
c-maf-mediated Th2 pathway in which Tc-mip but not c-mip might play
a potent role.
6-Tc-mip-overexpressed T cells display striking changes in
cellular redistribution of cytoskeleton-associated L-plastin.
Our precedent results support the role of TCR activation in c-maf
signaling pathway, as it has been previously reported (12), but
upstream proteins involved in c-maf induction remain unidentified.
Since Tc-mip behaves as a proximal inducer of c-maf expression, we
wished to determine whether Tc-mip could mimic TCR signaling. To test
this hypothesis, we analysed the distribution of L-plastin, a cytoskeleton
protein that is upregulated  in active MCNS disease (3). We transfected
Jurkat T cells with Tc-mip and c-mip expression vectors and 16 hours
later, cells were recovered from medium alone, fixed and incubated
with L-plastin monoclonal antibody. T cells transfected with c-mip or
empty vector exhibited an homogeneously distribution of L-Plastin in
the cytoplasm area, whereas Tc-mip induced a cell clustering with
distribution changes of L-plastin that was relocalized in cytoplasmic
zones facing the cell contact (Fig 6A). We conclude that overexpression
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of Tc-mip promotes the cytoskeleton rearrangement partially
mimicking TCR stimulation. To assess whether this effect involved the
PI3-kinase pathway, we treated Tc-mip-transfected cells with
wortmanin, a PI3-k inhibitor. We found that cell clustering as well as
the relocalization of L-plastin were not affected by wortmanin
treatment (Fig 6B), suggesting that Tc-mip-induced cytoskeleton
reorganization was independent of PI3 kinase enzymatic activity.
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Discussion
We isolated from T lymphocyte of patients with MCNS a new protein,
which induce c-maf transcription factor. This protein, Tc-mip
corresponds to a truncated form of the protein c-mip, both proteins
being produced by a single gene through two alternative transcripts.
The main difference between these proteins is a deletion in Tc-mip of
the N-terminal part of a PH domain which is fully functional in c-mip.
These two proteins display striking differences in cellular expression
and distribution, as well as in functional characteristics.
We showed that Tc-mip is specifically expressed in CD4+ T cells in
patients with MCNS and plays a driving role in c-maf-mediated Th2
signaling pathway. Such findings extend our previous data regarding
the specific recruitment of c-maf in MCNS (Valanciute A., submitted).
Conversely, c-mip is mainly detectable in PBMC of normal subjects and
exerts slight effects on c-maf expression that is restricted to cytoplasmic
compartment.
Under unstimulated conditions, c-mip and Tc-mip proteins were weakly
or not detected despite the basal expression of their respective
transcripts, as reported for other genes expressed in immune cells (13).
Under stimulation conditions under which an increase in (Ca2+)i occurs
(e.g. PMA plus ionomycin), we observed a dramatic fall in Tc-mip and c-
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mip mRNA levels. It is likely that these agents activate PKC, which exerts
a negative regulatory role on Tc-mip/c-mip signaling pathway as
recently demonstrated for the PI3k/AKT pathway (14). On the other
hand, under Th skewing conditions, Tc-mip is preferentially recruited
in Th2 but not in Th1 cells. In addition c-maf is induced in Tc-mip-
transfected T cells and there is an increase of IL-4 promoter activity.
The IL-4 induction in Tc-mip-, and to a lesser extent, in c-mip-
overexpressing T cells, was observed only after TCR engagement
following stimulation by the anti-CD3 antibody. These data suggest that
additional signals, stemming from TCR, are required for the IL-4
induction by c-maf, as previouly reported (12).
Intracellular molecules, known as cytosolic adapter proteins (CAPs) and
lacking intrinsic enzymatic or transcriptional activity, contain modular
domains which serve to recruit proteins to couple proximal events
initiated by TCR ligation with more distal signaling pathways. Tc-mip/c-
mip might fall into this CAP family as the first protein identified so far
and linking TCR proximal signaling to c-maf transcription factor.
By comparison, NFATc-mediated Th2 signaling uses apparently distinct
pathway, involving the activation of lck and the phosphactivation of the
PH domain-containing protein Itk/Emt, a T cell associated Tec kinase
(15). As matter of fact Th2 development fails in lck-deficient T cells
(16). Nuclear localization of NFATc is sharply reduced in itk-deficient T
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cells upon stimulation by anti-TCR/CD28 (17). However, activation of
PKC with calcium ionophore restores NFATc-mediated IL-4 expression.
Importantly, Itk does not exhibit any influence on Th1 cytokines (18).
These data fundamentally differentiate Itk/Emt from Tc-mip by at least
two aspects: i)Tc-mip bypasses the requirement for calcium signaling;
ii) Tc-mip induces c-maf and represses the IFN g  expression.
Nevertheless, whether the downregulation of IFNg  is a direct effect of
Tc-mip or a consequence of the induction of c-maf remains to be
clarified.
PH domain-containing proteins are members of a large family involved
in cellular signaling (19), (20) (21). The consensus sequence of the PH
domains is weak but they share similar core b  sandwich structure (22).
The PH domains comprise approximately 100 amino acids, likely to
recruit molecules to the membrane by specific interactions with
phosphoinositide lipids (22). These interactions might contribute to the
attachment of the plasma membrane to the cytoskeleton through lipid-
protein and protein-protein interactions leading to a regulation of the
cytoskeleton organization (23). We showed here that Tc-mip partially
mimics TCR signaling and induced T cell clustering and refolding of the
cytoskeleton protein L-plastin, independently of PI3 kinase pathway.
The truncation of the PH domain of Tc-mip is associated with a nuclear
location of the protein. This suggests that the PH domain of c-mip acts
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cooperatively with membrane phosphoinositides to cluster c-mip at and
near the plasma membrane. The nuclear translocation of Tc-mip might
result from the alteration of the b  sheet structure present in the
phosphoinositide-binding module of the PH domain of c-mip, as
previously shown for other PH domain-containing proteins (23) (24)
(25).
The inhibitory role of the PH domain on cellular signaling has been
documented for other proteins. The PH domain of the guanine
nucleotide exchange factors (GEFs) Vav-1, acts as a negative,
intramolecular regulator of Dbl homology (DH) domain function.
Mutations in the PH domain alters the phosphoinositide binding of
Vav1 and induces an increase in GEF activity (26). In addition, a Vav
variant, lacking the PH domain, induces JNK activation leading to
cytoskeletal reorganization (27). As other examples, deletion of the PH
domain of the protein kinase D (PKD) or point mutation in PH domain
from Bruton’s tyrosine kinase (BTK), increased kinase activities (28,
29).
Alterations of the PH domain have also been associated with several
human disease: i) a point mutation in the PH domain of Btk is
associated with X-linked agammaglobulinaemia (30); ii) alterations in
the DH-PH domain of proteins such as Ost, Lfc, Dbs or the FGD-1 gene
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are implicated in human oncogenesis and developmental disorders (31)
(32) (33) (34).
Inasmuch that c-mip constitutes the normal protein isoform in T
lymphocytes of normal subjects, the occurrence of Tc-mip at high level
in MCNS patients allows important regulatory changes in the putative
signaling pathway. Truncation of the PH domain might suppress the
anchorage of Tc-mip to membrane-phosphoinositides, precluding
proximal interactions of T-cmip with negatively regulating molecules.
Nevertheless, Tc-mip conserves other domains allowing its interactions
with downstream molecules. Following TCR stimulation, Tc-mip
upregulates the activation cascade that ultimately induces c-maf and
affect its cytokine repertoire.
Growing evidence suggests that glomerular diseases with nephrotic
syndrome are associated with alterations of cytoskeleton scaffold in
podocyte cells (35) (36). Since Tc-mip/c-mip is also preferentially
expressed in kidney, it has to be demonstrated whether Tc-mip alters
the cytoskeleton organization in Minimal Change Nephrotic Syndrome.
In conclusion, we identified in this study a new protein, Tc-mip, which
is specifically recruited during MCNS. We showed that Tc-mip links
TCR-mediated signal to the activation of c-maf Th2 specific factor. The
presence of a truncated PH domain allows a nuclear translocation of the
protein which promote a high c-maf expression level in MCNS patients.
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It also gives additional evidence regarding the inhibitory function of
the PH domain on protein activity and its critical role on protein
localization. Finally, it gives strong support to the potential
involvement of unknown alternative species of transcripts in human
diseases.
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Table 1. Sets of primers used in semiquantitative RT-PCR and for PCR
amplification of coding sequences of c-mip and Tc-mip. The
oligonucleotides sense (S) and antisense (AS) were selected from the
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sequences with the indicated Accession numbers. The size of each
amplified product, annealing temperature of each ologonucleotides ,
and the number of PCR cycles are indicated  (I: internal oligonucleotide




Figure 1 Comparative structure of c-mip and Tc-mip.
Partial c-mip and Tc-mip genes structure are reported are indicated on
the top and bottom of panel A. Both transcripts differ the first exon: c-
mip exon 1 encodes for 66 amino acid (aa) of which the 29 aa C-
terminal (position 38-66) contribute to PH domain (109 aa); Tc-mip
exon-1 encodes for 6 aa belonging to PH domain (87aa). Protein
structure was analyzed by Smart software (Simple Modular Architecture
Research Tool), which detected the PH domain (encoded by  exons 1, 2,
3 and 4 and the Leucine-rich repeats (LRR), encoded by the exon 19). B.
Prediction of b  sheet structures of the PH domain using the Garnier
Peptide structure tool (http://biotools.umassed.edu/cgi-
bin/biobin/garnier). Amino acid sequence corresponding to the PH
domain is indicated in bold characters.
Figure 2: Northern blot analysis of c-mip and Tc-mip
expression and differential expression of c-mip and Tc-mip
mRNA in PBMC subsets. Preferential induction of Tc-mip in
Th2.
A. Multiple tissue-Northern blots (Clontech) were hybridized with a 560
bp cDNA probe common to Tc-Mip and c-Mip and exposed on a
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phospho-imager Storm for 24h. PBMC: peripheral blood mononuclear
cells. LN: Lymph node; BM: Bone marrow; B: Brain; H: Heart; SK: Skeletal
muscle; C: Colon; T: Thymus; S: Spleen; K: Kidney; L: Liver; I: Intestine;
P: Placenta; Lu: Lung. B. Resting (-) and PMA/iono-activated (+) cells
were isolated and analyzed for c-mip and Tc-mip mRNA expression as
described under “Material and Methods”. The expression of GAPDH was
monitored in parallel. PBMC: peripheral blood mononuclear cells. BL: B
lymphocyte. C. Naive T cells were purified from blood umbilical cord,
then polarized under Th1 or Th2 skewing conditions and analyzed for
c-mip/Tc-mip and IL-4 mRNA expression by semiquantitative RT-PCR as
described under “Materiel and Methods.” The expression of GAPDH was
monitored in parallel.
Figure 3: Specific induction of Tc-mip in MCNS. A. RT-PCR
analyses of Tc-mip mRNA expression. Nine patients with MCNS were
studied in relapse and in remission as well as eight normal subjects and
four nephrotic patients with membranous nephropathy. The expression
of GAPDH was monitored in parallel, in order to control the initial
amount of mRNA. The lower panel shows quantification of the PCR
bands in panel A determined by using the Image Quant V 1.11 analysis
software, after normalization against the corresponding GAPDH bands;
B. induction of Tc-mip was higher in the CD4+ T cell subset. Total RNA
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from CD4+, non-CD4+ (nCD4) subsets was purified from PBMC of
patienTs with MCNS relapse, as described under "Material and
Methods" and analyzed for Tc-mip expression by RT-PCR.
C. Western blot analyses using anti-Tc-mip/c-mip antibody. Total
protein extracts (50 m g) of PBMC from six patients in relapse and six
normal subjects were tested for Tc-mip/c-mip expression; The blots
were stripped and reprobed with anti-actin antibodies; D.
immunostaining of PBMC of a pediatric patient with MCNS (4-year-old,
first relapse and remission). PBMC were purified, methanol fixed and
incubated with anti-Tc-mip/c-mip antibody, as described under
"Material and Methods" (X40, magnification).
Figure 4: Tc-Mip induces c-maf nuclear expression. A. RT-PCR
and Western blot analyses for c-maf expression in Jurkat cells
transfected with either Tc-mip, c-mip or empty vector, as described
under Materials and Methods. B. Immunofluorescence detection of c-
maf in transfected Jurkat cells. The data are representative of six
separate experiments. GAPDH and Actin were assayed as controlC. c-maf
DNA binding activity. EMSA analyses of nuclear extracts (15 m g) from
Tc-mip- (Lane 1-3) and c-mip- (Lane 4) transected jurkat cells. The
specificity of the band shift (black arrow) was demonstrated by the loss
of this band, in the presence of the mutant MARE oligonucleotide (mt
40
MARE, line 5). D. Confocal imaging of Tc-mip and c-mip after transient
transfection in Jurkat cells with respective expression vectors. This
result is representative of several cells in four independent experiments.
Figure 5: Tc-Mip induces the transactivation of the IL4 gene
and inhibits the INF  expression in stimulated Jurkat T cells.
A. Jurkat T cells were transiently co-transfected with the IL-4/CAT
plasmide and either Tc-mip, c-mip or empty vector. Cells were then
incubated with medium alone or with anti-OkT3 monoclonal antibody
as described under “Material and Methods”. Data are expressed as fold
induction of intracellular CAT and represent the mean results of 4
independent experiments. B. RT-PCR of total RNA extracted using IL4
and INF g  specific primers (table 1). The expression of GAPDH was
monitored in parallel.
Figure 6 Overexpression Tc-mip in T cells induces a spatial
and PI3 kinase-independent redistribution of cytoskeleton-
associated L-plastin. A Immunofluorescence detection of L-plastin in
unstimulated Jurkat cells transfected with either Tc-mip, c-mip or
empty vector. The data are representative of three independent
experiments. B Pharmacologic inhibitors of PI3-K did not inhibit
redistribution of cytoskeleton-associated L-plastin. Jurkat T cells
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transfected with T-cmip and wortmanin (100 nM) was added to medium
culture, six hours following transfection and left overnight. This result
was reproduced in three independent experiments.
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